EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER
The invention relates to the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (preferably recurrent squamous cell carcinoma of the head and neck) with a compound which is (3-ethynyl-phenyl)-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yl]-amine (NRC-2694)...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
20.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!